• Arsenic/Creatinine Ratio, Random, Urine
  • Tetanus Toxoid, IgE
  • Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum
  • Ferrochelatase (FECH) Gene Mutation Analysis
  • 17-Ketosteroids, Urine
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Interleukin 6 (IL-6), Serum
  • Fragile X, FMR1 Gene Mutation Analysis
  • MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
  • Chromosome Analysis, Solid Tumors
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
Medical Test

Additional ICD10
Access to Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis is restricted.